IMS and Quintiles to merge and create $17 billion firm; Biogen spins off hemophilia company; Google partners with the National Health Service
Learn more about the top therapeutic categories by sales, top companies by revenue, top drugs by sales, and more.
Express Scripts to roll out pricing response program; the FDA approves new Parkinson's disease treatment; Regeneron's plaque psoriasis drug hits endpoint
Harvoni and Sovaldi growth begins to slow; drugmakers spend billions to buy developers of cancer therapies; Valeant discloses new investigations
The drugmaker said it plans to increase its investment in DTC for the immuno-oncology drug.
Pfizer settles rebate suit; Sanofi moves to acquire Medivation; AstraZeneca sells US rights to gout drug
The Senate committee on Aging said Valeant's missteps go beyond price hikes and that its business model is fundamentally to blame.
The MM&M Women to Watch, part of our inaugural Hall of Femme, salutes 20 aspiring healthcare commercial and marketing execs distinguishing themselves.
The 16 women profiled here number among those who have bridged the gender gap in agencies, biopharma, and medtech.
Publicis Healthcare Communications Group has hired Kipp Jarecke-Cheng as global chief communications officer.
Click here to learn about the Agency Issue.
- When it comes to professional ads, print makes its comeback
- Amgen takes issue with yet-to-be published multiple-myeloma drug report
- How Watson for Oncology is advancing cancer care
- Creative partners should push pharma clients to tell better stories
- Following positive outcomes data, a new diabetes class is on the rise